We are live on ! Find out more
LSA

L & S Advisors Portfolio holdings

AUM $795M
1-Year Est. Return 52.77%
This Fund
S&P 500
This Quarter Est. Return
+9.07%
1 Year Est. Return
+52.77%
3 Year Est. Return
+187.16%
5 Year Est. Return
+324.2%
10 Year Est. Return
+1,741.32%
AUM
$251M
AUM Growth
+$63.7M
Cap. Flow
+$47.8M
Cap. Flow %
19.04%
Top 10 Hldgs %
44.41%
Holding
104
New
24
Increased
40
Reduced
18
Closed
22

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$6.02M
2
MMM icon
3M
MMM
+$4.44M
3
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
+$4.1M
4
CLR
CONTINENTAL RESOURCES INC.
CLR
+$4.04M
5
HAL icon
Halliburton
HAL
+$3.91M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$3.73M
2
BMY icon
Bristol-Myers Squibb
BMY
+$2.49M
3
QCOM icon
Qualcomm
QCOM
+$2.27M
4
KLAC icon
KLA
KLAC
+$2.25M
5
AMGN icon
Amgen
AMGN
+$2.13M

Sector Composition

Rank Sector Weight
1 Communication Services 23.8%
2 Energy 17.91%
3 Industrials 17.42%
4 Healthcare 13.85%
5 Materials 5.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARCC icon
76
Ares Capital
ARCC
$13.5B
$288K 0.11%
16,152
+1,565
+11% +$26.9K
ETN icon
77
Eaton
ETN
$157B
$288K 0.11%
3,728
-26,810
-88% -$1.99M
PCAR icon
78
PACCAR
PCAR
$69.6B
$283K 0.11%
6,750
+940
+16% +$40.1K
LYB icon
79
LyondellBasell Industries
LYB
$19.5B
$282K 0.11%
2,883
+451
+19% +$42.9K
KKR icon
80
KKR & Co
KKR
$89.2B
$250K 0.1%
+10,283
New +$239K
ADBE icon
81
Adobe
ADBE
$89.5B
– –
-31,753
Closed -$2.09M
AMGN icon
82
Amgen
AMGN
$203B
– –
-17,270
Closed -$2.13M
BAC icon
83
Bank of America
BAC
$435B
– –
-117,961
Closed -$2.03M
BMY icon
84
Bristol-Myers Squibb
BMY
$127B
– –
-47,870
Closed -$2.49M
CAH icon
85
Cardinal Health
CAH
$53.4B
– –
-3,929
Closed -$275K
FDX icon
86
FedEx
FDX
$74.5B
– –
-15,338
Closed -$2.03M
GILD icon
87
Gilead Sciences
GILD
$161B
– –
-28,410
Closed -$2.01M
GOOG icon
88
Alphabet (Google) Class C
GOOG
$3.9T
– –
-11,443
Closed -$318K
HIG icon
89
Hartford Financial Services
HIG
$38.5B
– –
-6,853
Closed -$242K
HSY icon
90
Hershey
HSY
$35.4B
– –
-2,613
Closed -$273K
KLAC icon
91
KLA
KLAC
$275B
– –
-325,410
Closed -$2.25M
MET icon
92
MetLife
MET
$61B
– –
-9,270
Closed -$436K
PRGO icon
93
Perrigo
PRGO
$1.4B
– –
-13,023
Closed -$2.01M
QCOM icon
94
Qualcomm
QCOM
$176B
– –
-28,761
Closed -$2.27M
SMH icon
95
VanEck Semiconductor ETF
SMH
$67.6B
– –
-42,614
Closed -$972K
TRN icon
96
Trinity Industries
TRN
$2.97B
– –
-78,501
Closed -$2.04M
USB icon
97
US Bancorp
USB
$99.6B
– –
-6,068
Closed -$260K
XBI icon
98
State Street SPDR S&P Biotech ETF
XBI
$10.1B
– –
-19,716
Closed -$936K
XLF icon
99
State Street Financial Select Sector SPDR ETF
XLF
$55.6B
– –
-22,028
Closed -$432K
XLNX
100
DELISTED
Xilinx Inc
XLNX
– –
-37,381
Closed -$2.03M
1 2 3
4
5

Similar funds

Legacy Financial Group (Iowa)
Legacy Financial Group (Iowa) Des Moines, Iowa $795M AUM 12.87% 1-Year Est. Return
ACM
Atika Capital Management New York $796M AUM 167.57% 1-Year Est. Return
SC
Soundwatch Capital Rowayton, Connecticut $793M AUM 15.45% 1-Year Est. Return
AGA
Arkos Global Advisors Houston, Texas $797M AUM 15.28% 1-Year Est. Return
ATS
Ashton Thomas Securities Rochester, New York $797M AUM 18.33% 1-Year Est. Return
RIM
Rovida Investment Management Grand Cayman, Cayman Islands $797M AUM 111.83% 1-Year Est. Return
ACM
Ashe Capital Management Englewood Cliffs, New Jersey $797M AUM 4.79% 1-Year Est. Return
CAM
CenterStar Asset Management Chicago, Illinois $797M AUM 28.71% 1-Year Est. Return

L & S Advisors's Q2 2014 Portfolio in Review

As of Q2 2014, L & S Advisors held 104 positions worth $251M, up 34% from $187M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

L & S Advisors deployed $47.8M of net new capital in Q2 2014, opening 24 new positions and adding to 40 existing holdings. Its largest new stake was AbbVie: 114,721 shares worth $6.47M.

By sector, the portfolio is most concentrated in Communication Services at 24% of assets, down from 29% a quarter earlier, followed by Energy and Industrials.

On the sell side, the largest reduction was Pfizer, an estimated $3.73M trimmed.

  • L & S Advisors's largest Q2 2014 buy was AbbVie: 114,721 shares worth $6.47M.
  • L & S Advisors added most to KRAFT FOODS GROUP INC COM STK (VA) in Q2 2014, an estimated $4.1M increase.
  • L & S Advisors's biggest Q2 2014 reduction was Pfizer, cutting an estimated $3.73M.
  • L & S Advisors fully exited Bristol-Myers Squibb in Q2 2014, selling an estimated $2.49M.
  • L & S Advisors's ten largest holdings make up 44% of its $251M portfolio in Q2 2014.
  • L & S Advisors opened 24 new positions and closed 22 in Q2 2014.
  • L & S Advisors's portfolio value rose 34% quarter-over-quarter to $251M.

Based on L & S Advisors's 13F filing for Q2 2014, filed 14 Aug 2014.